Summary & Overview
HCPCS G9411: CIED Infection Requiring Device Removal or Surgical Revision
HCPCS Level II code G9411 represents care for patients who were not admitted within 180 days after a cardiovascular implantable electronic device (CIED) implantation, replacement, or revision when that index procedure was complicated by infection requiring device removal or surgical revision. This code identifies post-procedural infection events linked to device management and is relevant for inpatient and outpatient surgical billing and quality tracking nationwide. Key payers in the national landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the code’s clinical context, typical sites of service, and common billing considerations. The publication outlines what the code captures clinically, how major payers treat this service line, and where to look for related billing and policy guidance. It also flags areas where input data were not provided so readers can seek supplementary sources. This summary aims to support coding professionals, hospital billing leaders, and policy analysts in understanding the clinical scenario tied to G9411 and the types of claims activity this HCPCS Level II code represents.
Billing Code Overview
HCPCS Level II code G9411 describes a patient who is not admitted within 180 days following a cardiovascular implantable electronic device (CIED) implantation, replacement, or revision when the procedure was associated with an infection requiring device removal or surgical revision. The service type is infection-related device removal or surgical revision associated with a CIED. The typical site of service is an inpatient or outpatient surgical setting where device explantation or revision for infection is performed.
Clinical & Coding Specifications
Clinical Context
A 68-year-old male with ischemic cardiomyopathy and a previously implanted cardiac implantable electronic device (CIED) presents with fever, erythema and purulent drainage at the left subclavian pocket site and positive blood cultures for Staphylococcus aureus. He is evaluated in the outpatient electrophysiology clinic and admitted to the ambulatory surgical center for device removal and pocket debridement. The procedure includes explantation of the generator and leads, wound irrigation, and plans for delayed reimplantation after clearance of infection. The clinical workflow includes pre-procedure evaluation (temperature, blood cultures, device interrogation), informed consent, peri-procedural antibiotics, device and lead extraction in the procedure suite, documentation of operative findings (pocket infection, lead vegetations), specimen collection for culture, and post-procedure wound care and follow-up.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typically required (extensive infected tissue debridement beyond standard explantation). |
23 | Unusual anesthesia | Use when general anesthesia is required for a procedure normally done with local/regional anesthesia due to infection complexity or patient factors. |